BioCardia Announces Clarification and Next Steps on its Autologous CardiAMP Cell Therapy Programs
06 sept. 2023 07h15 HE
|
BioCardia, Inc.
SUNNYVALE, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
BioCardia Reports Second Quarter 2023 Business Highlights and Financial Results
09 août 2023 16h05 HE
|
BioCardia, Inc.
SUNNYVALE, Calif., Aug. 09, 2023 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...
BioCardia Announces FDA Completes Review of Proposed Adaptive Statistical Analysis Design for Ongoing CardiAMP Cell Therapy in Heart Failure Pivotal Study
20 juin 2023 17h14 HE
|
BioCardia, Inc.
SUNNYVALE, Calif., June 20, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
BioCardia Announces Helix™ Biotherapeutic Delivery Patent Issuance in Japan
08 juin 2023 07h00 HE
|
BioCardia, Inc.
SUNNYVALE, Calif., June 08, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
BioCardia Presentations at Next Generation Cardiovascular Drug Development Summit Now Available
28 avr. 2023 07h00 HE
|
BioCardia, Inc.
SUNNYVALE, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
Daxor Corporation Announces Significant Expansion With Five Hospitals Implementing Its BVA-100® Blood Volume Diagnostic for Heart Failure Patients
27 mars 2023 08h00 HE
|
Daxor Corporation
Oak Ridge, TN, March 27, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces five new hospitals have implemented the...
New Research: Preeclampsia-related heart failure disproportionately impacts Black mothers
08 févr. 2023 09h00 HE
|
Truveta
BELLEVUE, Wash., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new maternal heart health and health equity research from Truveta Studio that explored nearly 500,000 female patient...
Impulse Dynamics Announces Chief Financial Officer Transition
25 janv. 2022 10h00 HE
|
Impulse Dynamics
MARLTON, N.J., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Impulse Dynamics N.V., a company dedicated to improving the lives of people with heart failure, today announced the appointment of Harriss T. Currie...
CardiAMP Cell Therapy Heart Failure Trial to be Featured in Two Presentations at Heart Failure Society of America Annual Meeting 2021
10 sept. 2021 08h00 HE
|
BioCardia, Inc.
SAN CARLOS, Calif., Sept. 10, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a company focused on developing cellular and cell derived therapeutics for the treatment of cardiovascular and...
Impulse Dynamics Expands Commercial Leadership Team
19 juil. 2021 08h58 HE
|
Impulse Dynamics
MARLTON, N.J., July 19, 2021 (GLOBE NEWSWIRE) -- Impulse Dynamics (USA) Inc., a company dedicated to improving the lives of people with heart failure (HF), today announced the appointment of Jason...